No connection

Search Results

GNSS vs HIT

GNSS
Genasys Inc.
BEARISH
Price
$1.80
Market Cap
$81.4M
Sector
Technology
AI Confidence
90%
HIT
Health In Tech, Inc.
BEARISH
Price
$1.34
Market Cap
$87.8M
Sector
Technology
AI Confidence
85%

Valuation

P/E Ratio
GNSS
--
HIT
67.0
Forward P/E
GNSS
11.61
HIT
7.24
P/B Ratio
GNSS
45.0
HIT
4.51
P/S Ratio
GNSS
1.6
HIT
2.64
EV/EBITDA
GNSS
-6.93
HIT
29.98

Profitability

Gross Margin
GNSS
40.66%
HIT
62.82%
Operating Margin
GNSS
-1.48%
HIT
-2.27%
Profit Margin
GNSS
-29.19%
HIT
3.84%
ROE
GNSS
-191.92%
HIT
8.45%
ROA
GNSS
-12.77%
HIT
4.92%

Growth

Revenue Growth
GNSS
145.9%
HIT
53.1%
Earnings Growth
GNSS
--
HIT
--

Financial Health

Debt/Equity
GNSS
9.35
HIT
0.01
Current Ratio
GNSS
0.73
HIT
3.13
Quick Ratio
GNSS
0.45
HIT
2.31

Dividends

Dividend Yield
GNSS
--
HIT
--
Payout Ratio
GNSS
0.0%
HIT
0.0%

AI Verdict

GNSS BEARISH

Genasys Inc. exhibits critical financial instability, highlighted by a weak Piotroski F-Score of 2/9 and a dangerous Debt/Equity ratio of 9.35. While the company is experiencing hyper-growth in revenue (145.90% YoY), this has not translated into operational efficiency or earnings reliability, as evidenced by 0/4 earnings beats in the last year. Severe liquidity constraints (Current Ratio 0.73, Quick Ratio 0.45) and a massive Price-to-Book ratio of 45.00 suggest the stock is priced on speculative growth rather than fundamental value. The combination of high leverage and consistent earnings misses creates a high-risk profile despite the optimistic analyst target price.

Strengths
Exceptional YoY revenue growth of 145.90%
Strong gross margins at 40.66%
Low Price-to-Sales ratio (1.60) relative to growth
Risks
Extreme leverage with a Debt/Equity ratio of 9.35
Severe liquidity risk with a Quick Ratio of 0.45
Consistent failure to meet earnings estimates (0/4 beats)
HIT BEARISH

HIT presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe technical deterioration. While the company exhibits strong revenue growth (53.10%) and an exceptionally clean balance sheet (Debt/Equity 0.01), it is trading at a massive premium to its Graham Number ($0.37) and Intrinsic Value ($0.14). The stock is currently in a freefall with a 0/100 technical trend and a 60.8% decline over the last six months, coupled with a poor earnings track record of 0/4 beats.

Strengths
Strong YoY and Q/Q revenue growth of ~53%
Negligible debt levels (Debt/Equity 0.01)
Robust liquidity with a Current Ratio of 3.13
Risks
Severe bearish technical trend (0/100 score)
Significant overvaluation relative to Graham and Intrinsic values
Negative operating margin (-2.28%) indicating operational inefficiency

Compare Another Pair

GNSS vs HIT: Head-to-Head Comparison

This page compares Genasys Inc. (GNSS) and Health In Tech, Inc. (HIT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile